Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis

被引:0
作者
Buessing, Arndt [1 ]
Raak, Christa [1 ]
Ostermann, Thomas [1 ]
机构
[1] Univ Witten Herdecke, Fac Hlth, Ctr Integrat Med, D-58239 Herdecke, Germany
关键词
PROSPECTIVE CONTROLLED COHORT; LONG-TERM THERAPY; MATCHED-PAIR DESIGN; ALBUM L. EXTRACTS; CLINICAL-TRIALS; HETEROGENEITY; COMPLEMENTARY; PERFORMANCE; PLACEBO; HEALTH;
D O I
10.1155/2012/219402
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives. The aim of this meta-analysis was to determine the effectiveness of the fermented plant extract Iscador, produced from the white-berry European mistletoe, in the treatment of patients with cancer with respect to quality-of-life- (QoL-) associated measures. Methods. We searched databases such as PubMed/Medline, Excerpta Medica Database (EMBASE), CAMbase, and other for controlled clinical studies on parameters associated with QoL. Outcome data were extracted and converted into standardized mean differences and their standard errors. Results. Thirteen prospective and controlled studies which met the inclusion/exclusion criteria reported positive effects in favor of the Iscador application. A random-effect meta-analysis estimated the overall treatment effect at standardized mean difference = 0.56 (CI: 0.41 to 0.71, P < .0001). However, the methodological quality of the studies was poor. Conclusions. The analyzed studies give some evidence that Iscador treatment might have beneficial short-time effects on QoL-associated dimensions and psychosomatic self-regulation.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 47 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
[Anonymous], COMPLEMENTARY ONCOLO
[3]  
[Anonymous], 2001, ALTERN THER HEALTH M
[4]  
[Anonymous], EVIDENCE BASED COMPL
[5]  
[Anonymous], PHYSL THERAPEUTISCHE
[6]  
[Anonymous], UGESKRIFT LAEGER
[7]  
[Anonymous], MINERVA MED
[8]  
[Anonymous], FORTSCHRITTE MISTELT
[9]  
[Anonymous], SCHWEIZER Z GANZHEIT
[10]  
[Anonymous], 1986, Meta-analysis: Quantitative methods for research synthesis